Patents by Inventor Erica Kraynack

Erica Kraynack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Certain chemical entities, compositions and methods
    Patent number: 8871768
    Abstract: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Grant
    Filed: May 17, 2013
    Date of Patent: October 28, 2014
    Assignee: Cytokinetics, Inc.
    Inventors: Bradley P. Morgan, David J. Morgans, Alex Muci, Pu-Ping Lu, Erica A. Kraynack, Todd Tochimoto
  • Certain chemical entities, compositions, and methods
    Patent number: 8653081
    Abstract: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Grant
    Filed: March 29, 2013
    Date of Patent: February 18, 2014
    Assignee: Cytokinetics, Inc.
    Inventors: Bradley P. Morgan, Erica A. Kraynack, Pu-Ping Lu, Alex Muci, David J. Morgans
  • CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
    Publication number: 20130324549
    Abstract: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Application
    Filed: May 17, 2013
    Publication date: December 5, 2013
    Applicant: Cytokinetics, Inc.
    Inventors: Bradley P. MORGAN, David J. Morgans, Alex Muci, Pu-Ping Lu, Erica A. Kraynack, Todd Tochimoto
  • CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
    Publication number: 20130296335
    Abstract: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Application
    Filed: March 29, 2013
    Publication date: November 7, 2013
    Inventors: Bradley P. MORGAN, Erica A. KRAYNACK, Pu-Ping LU, Alex MUCI, David J. MORGANS
  • Certain Chemical entities, compositions and methods
    Patent number: 8445495
    Abstract: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Grant
    Filed: June 11, 2009
    Date of Patent: May 21, 2013
    Assignee: Cytokinetics, Inc.
    Inventors: Bradley P. Morgan, David J. Morgans, Jr., Alex Muci, Pu-Ping Lu, Erica A. Kraynack, Todd Tochimoto
  • Certain chemical entities, compositions and methods
    Patent number: 8410108
    Abstract: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Grant
    Filed: May 3, 2010
    Date of Patent: April 2, 2013
    Assignee: Cytokinetics, Inc.
    Inventors: Bradley P. Morgan, Erica A. Kraynack, Pu-Ping Lu, Alex Muci, David J. Morgans, Jr.
  • Compounds, compositions and methods
    Patent number: 7989455
    Abstract: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Grant
    Filed: December 14, 2006
    Date of Patent: August 2, 2011
    Assignee: Cytokinetics, Inc.
    Inventors: Bradley P. Morgan, David J. Morgans, Jr., Alex Muci, Pu-Ping Lu, Erica A. Kraynack, Todd Tochimoto
  • Compounds, compositions and methods
    Patent number: 7910743
    Abstract: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Grant
    Filed: May 20, 2009
    Date of Patent: March 22, 2011
    Assignee: Cytokinetics, Inc.
    Inventors: Bradley P. Morgan, Alex Muci, Erica Kraynack, Pu-Ping Lu, Todd Tochimoto, David J. Morgans, Jr.
  • Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas
    Patent number: 7825120
    Abstract: Certain substituted ((piperazin-1-ylmethyl)benzyl)urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and may be useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Grant
    Filed: December 13, 2006
    Date of Patent: November 2, 2010
    Assignee: Cytokinetics, Inc.
    Inventors: Bradley P. Morgan, Alex Muci, Erica A. Kraynack, Todd Tochimoto, Pu-Ping Lu, David J. Morgans, Jr.
  • Certain Chemical Entities, Compositions and Methods
    Publication number: 20100210634
    Abstract: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Application
    Filed: May 3, 2010
    Publication date: August 19, 2010
    Inventors: Bradley P. Morgan, Erica A. Kraynack, Pu-Ping Lu, Alex Muci, David J. Morgans, JR.
  • Certain indanyl urea modulators of the cardiac sarcomere
    Patent number: 7718657
    Abstract: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Grant
    Filed: December 13, 2006
    Date of Patent: May 18, 2010
    Assignee: Cytokinetics, Inc.
    Inventors: Bradley P. Morgan, Erica A. Kraynack, Pu-Ping Lu, Alex Muci, David J. Morgans, Jr.
  • Certain Chemical Entities, Compositions and Methods
    Publication number: 20100029680
    Abstract: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Application
    Filed: June 11, 2009
    Publication date: February 4, 2010
    Inventors: Bradley P. Morgan, David J. Morgans, JR., Alex Muci, Pu-Ping Lu, Erica A. Kraynack, Todd Tochimoto
  • Compounds, Compositions and Methods
    Publication number: 20090324511
    Abstract: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Application
    Filed: May 20, 2009
    Publication date: December 31, 2009
    Inventors: Bradley P. Morgan, Alex Muci, Erica Kraynack, Pu-Ping Lu, Todd Tochimoto, David J. Morgans, JR.
  • Compounds, compositions and methods
    Patent number: 7538223
    Abstract: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Grant
    Filed: August 4, 2006
    Date of Patent: May 26, 2009
    Assignee: Cytokinetics, Inc.
    Inventors: Bradley P. Morgan, Alex Muci, Erica Kraynack, Pu-Ping Lu, Todd Tochimoto, David J. Morgans, Jr.
  • Certain chemical entities, compositions and methods
    Publication number: 20070208000
    Abstract: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Application
    Filed: December 13, 2006
    Publication date: September 6, 2007
    Inventors: Bradley Morgan, Pu-Ping Lu, Alex Muci, Erica Kraynack, Todd Tochimoto, David Morgans
  • Compounds, compositions and methods
    Publication number: 20070197497
    Abstract: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Application
    Filed: December 14, 2006
    Publication date: August 23, 2007
    Inventors: Bradley Morgan, David Morgans, Alex Muci, Pu-Ping Lu, Erica Kraynack, Todd Tochimoto
  • Certain chemical entities, compositions and methods
    Publication number: 20070197507
    Abstract: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Application
    Filed: December 13, 2006
    Publication date: August 23, 2007
    Inventors: Bradley Morgan, Erica Kraynack, Pu-Ping Lu, Alex Muci, David Morgans
  • Certain chemical entities, compositions and methods
    Publication number: 20070197504
    Abstract: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Application
    Filed: December 13, 2006
    Publication date: August 23, 2007
    Inventors: Bradley Morgan, Alex Muci, Erica Kraynack, Todd Tochimoto, Pu-Ping Lu, David Morgans
  • Certain chemical entities, compositions and methods
    Publication number: 20070161617
    Abstract: Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Application
    Filed: December 14, 2006
    Publication date: July 12, 2007
    Inventors: Bradley Morgan, David Morgans, Alex Muci, Pu-Ping Lu, Erica Kraynack, Todd Tochimoto
  • Compounds, compositions and methods
    Publication number: 20070078126
    Abstract: Certain substituted sulfonamide derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.
    Type: Application
    Filed: March 26, 2004
    Publication date: April 5, 2007
    Inventors: Bradley Morgan, Fady Malik, Erica Kraynack, Alexander Muci, Xiangping Qian, David Morgans